Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.
The Ontario Institute for Cancer Research (OICR) brings together a community of scientists, clinicians, patients and innovators to take on the biggest challenges in cancer.
Stay up to date with our latest stories, findings, and partnerships.
In the two decades since the Government of Ontario first launched the province’s very own cancer research institute, OICR has become a pillar of Ontario’s research and life sciences communities.
Our new report 20 Years of Changing Lives is a snapshot of OICR’s impact over the years, the difference it is making today and the future of cancer research in Ontario.
Through cutting-edge research, collaborative networks and strategic investments, we are improving health, building a stronger economy and making a global impact.
46,000+ patients accessed new cancer innovations through these OICR-supported clinical trials.
OICR and FACIT support more than 1,500 highly-skilled jobs in STEM fields on an annual basis, more than half of which are at start-ups across Ontario.
OICR supports cancer research at 20 communities across Ontario, including 10 universities, 25 hospitals and 10 institutes.
Be first to know about news, events and funding opportunities from OICR.
We’re accelerating and supporting cancer research across the province.
We deliver real-world solutions that are finding cancer earlier, treating it more effectively and improving outcomes in Ontario and around the world.
We drive the development and adoption of life-changing innovations.
We bolster Ontario’s global leadership in cancer research.
We invest in cancer research innovations to build economic value for Ontario.
Working with our commercialization partner FACIT, we support Ontario innovations to create local jobs and new companies, attract investment to the province and bring new discoveries to patients worldwide.
See the latest research news from Ontario’s cancer research institute.
OICR is leading a province-wide initiative to advance molecular residual disease (MRD) research and bring tests to patients. “Did you get it all?” It’s
OICR Drug Discovery is teaming up with Dr. Sheila Singh to develop a potentially game-changing new treatment option for the most aggressive form of
OICR funding is leveraging Ontario’s drug discovery expertise to answer the call for improved treatment options April 9, 2026 (Toronto) – Better cancer care
When treating colorectal, pancreatic and other cancers, oncologists often turn to a couple of commonly used chemotherapies, and while these medicines are an effective
- Hon. Nolan Quinn
Minister of Colleges, Universities, Research Excellence and Security
We support a thriving community of programs, networks and initiatives advancing cancer research in Ontario and beyond.
